Showing results (51-60 of 97) with videos related to
Sort By:
Pageof 10
BMC Cancer|March 23, 2006
Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experienceAlessandro Passardi, Ilaria Massa, Wainer Zoli, et al.Disease Markers|September 29, 2015
Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer PatientsSamanta Salvi, Giorgia Gurioli, Filippo Martignano, et al.Journal of Cellular Physiology|April 27, 2007
Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristicsMarco Rosetti, Wainer Zoli, Anna Tesei, et al.Tumori|February 8, 2013
Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancerMarco Montanari, Francesco Fabbri, Ermanno Rondini, et al.International Journal of Molecular Sciences|December 17, 2013
MMP-7 and fcDNA serum levels in early NSCLC and idiopathic interstitial pneumonia: preliminary studyPaola Ulivi, Gian Luca Casoni, Giovanni Foschi, et al.The International Journal of Biological Markers|March 9, 2016
CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abirateroneSamanta Salvi, Valentina Casadio, Salvatore Luca Burgio, et al.Oncology|July 8, 2011
The role of CXCR4 in the prediction of bone metastases from breast cancer: a pilot studyEmanuele Sacanna, Toni Ibrahim, Michele Gaudio, et al.Cellular Oncology (Dordrecht, Netherlands)|December 20, 2012
SLUG silencing increases radiosensitivity of melanoma cells in vitroChiara Arienti, Anna Tesei, Silvia Carloni, et al.Cancer Cell International|November 24, 2012
Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acidToni Ibrahim, Laura Mercatali, Emanuele Sacanna, et al.Journal of Cellular Physiology|July 11, 2008
Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cellsFrancesco Fabbri, Dino Amadori, Silvia Carloni, et al.Pageof 10